Skip to main content
TipRanks
Go Ultimate75% OFF

Clinigence Holdings (NUTX) Stock Price & Analysis

429 Followers

NUTX Stock Chart & Stats

$169.70-$3.97(-2.29%)
At close: 4:00 PM EST
$175$200$225Aug 24Sep 8Sep 21Oct 5Oct 19Nov 2Nov 16
Day’s Range
$166.08 - $178.20
52-Week Range
$83.99 - $226.16
Previous Close
$173.67
Volume
N/A
Average Volume (3M)
138.81K
Market Cap
$1.16B
Enterprise Value
$1.71B
Total Cash (Recent Filing)
$249.91M
Total Debt (Recent Filing)
$364.98M
Price to Earnings (P/E)
7.1
Beta
1.83
Next Earnings
Mar 04, 2027 (Est.)
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Strong Cash Generation

Operating and free cash flow closely track reported earnings, indicating strong earnings quality and internal funding capacity. This supports hospital expansion, technology investment, and resilience over the next several quarters, although sustaining this strength depends on reversing the recent cash-flow decline.

Hospital Volume And Expansion

Rising hospital visits and a visible development pipeline provide a structural path to expanding capacity and future revenue. Same-hospital growth alongside new openings suggests operating momentum is not dependent solely on acquisitions, while the planned hospital cadence can broaden the platform over time.

Improved Balance Sheet

materially lower leverage improves financial flexibility and reduces the burden carried by future operations compared with earlier periods. A stronger equity base should help support development spending and provide greater capacity to manage reimbursement or earnings volatility through the next several quarters.

Bears Say

Revenue And EBITDA Contraction

The decline in revenue and adjusted EBITDA shows that strong visit growth has not yet translated into sustained financial expansion. Continued contraction could pressure margins, reduce funding available for new facilities, and challenge the durability of the company’s currently strong profitability profile.

Reimbursement Uncertainty

Reimbursement outcomes remain exposed to regulatory change and inconsistent payer execution. Because the company relies substantially on the IDR process for billable visits, adverse legislation or weaker enforcement could reduce payment certainty, extend collections, and pressure revenue realization over time.

Cybersecurity Exposure

The disclosed data-security incident creates an ongoing operational, legal, and reputational exposure while the company determines what information was accessed. Potential patient, employee, provider, and business data involvement could increase remediation and notification obligations even though no material operating impact was identified so far.

Clinigence Holdings News

NUTX FAQ

What was Clinigence Holdings’s price range in the past 12 months?
Clinigence Holdings lowest stock price was $83.99 and its highest was $226.16 in the past 12 months.
What is Clinigence Holdings’s market cap?
Clinigence Holdings’s market cap is $1.16B.
When is Clinigence Holdings’s upcoming earnings report date?
Clinigence Holdings’s next earnings report is estimated for Mar 04, 2027 (not yet confirmed), which is in 106 days.
How were Clinigence Holdings’s earnings last quarter?
Clinigence Holdings released its earnings results on Nov 05, 2026. The company reported $5.71 earnings per share for the quarter, beating the consensus estimate of $5.542 by $0.168.
Is Clinigence Holdings overvalued?
According to Wall Street analysts Clinigence Holdings’s price is currently Undervalued.
Does Clinigence Holdings pay dividends?
Clinigence Holdings does not currently pay dividends.
What is Clinigence Holdings’s EPS estimate?
Clinigence Holdings’s EPS estimate is 5.87.
How many shares outstanding does Clinigence Holdings have?
Clinigence Holdings has 6,860,794 shares outstanding.
What happened to Clinigence Holdings’s price movement after its last earnings report?
Clinigence Holdings reported an EPS of $5.71 in its last earnings report, beating expectations of $5.542. Following the earnings report the stock price went down -6.755%.
Which hedge fund is a major shareholder of Clinigence Holdings?
Hedge funds hold Clinigence Holdings shares: the largest hedge-fund position in Clinigence Holdings is 71,886,003 shares, and hedge funds increased their holdings by 7.0K shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology